We are live on ! Find out more
BNGO icon

Bionano Genomics
BNGO

27 hedge funds and large institutions have $5.65M invested in Bionano Genomics in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

185% more capital invested

Capital invested by funds: $1.98M → $5.65M (+$3.67M)

117% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 6

100% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 4

35% more funds holding

Funds holding: 20 → 27 (+7)

3.97% less ownership

Funds ownership: 10.26% → 6.29% (-4%)

Holders
27
Holders Change
+7
Holders Change %
+35%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
8
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$3.37M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$191K
3
VF
Virtu Financial
New York
+$163K
4
Bank Julius Baer & Co
Bank Julius Baer & Co
Switzerland
+$64.7K
5
Northern Trust
Northern Trust
Illinois
+$52K

Top Sellers

Rank Fund Capital Flow
1
SCM
Sio Capital Management
New York
-$826K
2
Citadel Advisors
Citadel Advisors
Florida
-$115K
3
Barclays
Barclays
United Kingdom
-$77.2K
4
UBS Group
UBS Group
Switzerland
-$70.9K
5
BCM
Bayesian Capital Management
New York
-$51K

BNGO Hedge Fund Activity: Q3 2020 in Review

27 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Bionano Genomics (BNGO) for Q3 2020, worth a combined $5.65M — up 185% from $1.98M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new BNGO positions and 6 closed out — a net gain of 7 holders — while 8 added to existing stakes and 4 trimmed.

The largest buyer was Vanguard Group, adding an estimated $3.37M. The largest seller was Sio Capital Management, cutting an estimated $826K.

  • 27 institutional investors held Bionano Genomics (BNGO) as of Q3 2020, up from 20 in Q2 2020.
  • Funds reported $5.65M of Bionano Genomics stock for Q3 2020, up 185% quarter-over-quarter.
  • 13 funds opened new Bionano Genomics positions in Q3 2020 and 6 closed out, a net change of +7 holders.
  • The largest Bionano Genomics buyer in Q3 2020 was Vanguard Group, an estimated $3.37M added.
  • The largest Bionano Genomics seller in Q3 2020 was Sio Capital Management, an estimated $826K sold.

Based on aggregated 13F filings for Q3 2020.